A nurse is preparing to teach a client about the prescription of lithium (Eskalith) for the treatment of bipolar disorder. Which of the following statements should the nurse include in the teaching?

Choice A rationale:

Monitoring vital signs throughout the day is essential for a client experiencing mania, but it is not a specific intervention related to managing the manic state. Mania is associated with high energy levels and hyperactivity, which can affect vital signs. However, this intervention does not directly address the core symptoms of mania.

Choice B rationale:

Maintaining an environment with low stimuli is crucial for managing a client experiencing mania. Manic individuals are often highly sensitive to external stimuli, and a low-stimulation environment helps reduce agitation and potential exacerbation of manic behaviors.

Choice C rationale:

Discouraging the client from taking a nap during the day is not a suitable intervention for managing mania. Sleep disturbances are common during manic episodes, and attempting to restrict daytime naps might increase restlessness and agitation.

Choice D rationale:

Weighing the client every 3 to 4 days is not a specific intervention for managing mania. Weight monitoring might be relevant in certain contexts, such as if the client's medication regimen is associated with weight changes, but it does not directly address the manifestations of mania.

Choice E rationale:

Offering nutritional foods to the client every 2 hours is an important intervention for managing mania. Manic individuals often engage in impulsive behaviors, including neglecting self-care such as eating. Providing regular and nutritious meals helps stabilize blood sugar levels and supports the body's energy demands during this hyperactive phase.

Choice A rationale:

Sweating is not an adverse effect commonly associated with buspirone (Buspar). While some side effects like dizziness, nausea, and headache might occur, sweating is not typically reported as a significant adverse effect of this medication.

Choice B rationale:

Decreased appetite is a potential adverse effect of buspirone (Buspar). However, it is not the most concerning in this context. Anxiety disorders like generalized anxiety disorder can lead to appetite changes, and while this should be monitored, it is not a priority compared to more severe adverse effects.

Choice C rationale:

Discolored urine is not a common adverse effect of buspirone (Buspar). Buspirone is primarily used to treat anxiety and does not usually cause changes in urine color. This effect is unrelated to the medication and likely has a different underlying cause.

Choice D rationale:

Hallucinations are a concerning adverse effect that should be reported to the provider. Hallucinations are not a typical side effect of buspirone and might indicate a more serious issue or an interaction with other medications. Reporting this symptom promptly is crucial to ensuring the client's safety and well-being.